Novolog Cartridges: Indications, Side Effects, Warnings - Drugs.com
The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content. Generic Name: insulin aspart (IN-su-lin AS-part) Treating diabetes mellitus. NovoLog cartridges are usually used with a longer-acting insulin or insulin pump therapy. NovoLog cartridges are a fast-acting form of the hormone insulin. It works by helping your body to use sugar properly. This lowers the amount of glucose in the blood, which helps to treat diabetes. you are allergic to any ingredient in NovoLog cartridges you are having an episode of low blood sugar Contact your doctor or health care provider right away if any of these apply to you. Some medical conditions may interact with NovoLog cartridges. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you: if you are pregnant, planning to become pregnant, or are breast-feeding if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement if you have allergies to medicines, foods, or other substances if you drink alcoholic beverages or smoke if you have heart problems (eg, heart failure); kidney or liver problems; nerve problems; adrenal, pituitary, or thyroid problems; or diabetic ketoacidosis if you use 3 or more insulin injections per day if you are fasting, are on a low-salt (sodium) diet, have blood electrolyte problems (eg, high blood sodium levels, low blood potassium levels), or you exercise Some MEDICINES MAY INTERACT with NovoLog cartridges. Tell your health care provider if you are taking any other medicines, especially any of the following: Beta-blockers (eg, propranolol), clonidine, guanethidine, lithium, pentamidine, or reserpine because they may increase the risk of high or low bloo Continue reading >>
Novolog Penfill
Generic Name: insulin aspart (IN su lin AS part) Brand Name: NovoLOG, NovoLOG FlexPen, NovoLOG PenFill What is NovoLog PenFill? Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. NovoLog PenFill is a fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps working for 2 to 4 hours. NovoLog PenFill is used to improve blood sugar control in adults and children with diabetes mellitus. This medicine is sometimes used together with a long-acting or intermediate-acting insulin. NovoLog PenFill is used to treat type 2 diabetes in adults. NovoLog PenFill is also used to treat type 1 diabetes in adults and children who are at least 2 years old. NovoLog PenFill may also be used for purposes not listed in this medication guide. Important Information Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed. Before taking this medicine You should not use NovoLog PenFill if you are allergic to it, or if you are having an episode of hypoglycemia (low blood sugar). NovoLog PenFill is not approved for use by anyone younger than 2 years old. This medicine should not be used to treat type 2 diabetes in a child of any age. To make sure NovoLog PenFill is safe for you, tell your doctor if you have: liver or kidney disease; or low levels of potassium in your blood (hypokalemia). Tell your doctor if you also take pioglitazone or rosiglitazone (sometimes contained in combinations with glimepiride or metformin). Taking certain oral diabetes medicines while you are using insulin may increase your risk of serious heart problems. Follow your doctor's instructions about using insulin if you are pregnant or breast-feeding a baby. Blood sugar control is very important Continue reading >>
Medtronic Insulin Pump Will Use Novolog Cartridges
Medtronic insulin pump will use NovoLog cartridges Danish pharmaceutical company Novo Nordisk has inked a deal with a US medical device manufacturer that will extend the use of insulin cartridges from autoinjectors to external insulin pumps. The US company, Medtronic sells the Paradigm range of insulin pumps. At present, patients using these devices have to transfer insulin every two to three days from a vial to a reservoir that fits inside their pump. The new agreement with Novo aims to develop prefilled insulin cartridges that will eliminate this manual transfer process, simplifying pump therapy for Paradigm insulin pump users. The cartridges will contain Novo's NovoLog (insulin aspart) product, which was approved for use in pumps by the US Food and Drug Administration in 2002. NovoLog was the first so-called insulin analogue - modified versions of insulin that offer different pharmacokinetics to the parent molecule - to be approved for pump use, and has plenty of data supporting its value alongside pumps in providing good glucose control, according to Novo president Martin Soeters. The drug is a rapid-acting analogue that has been on the market since 2001 in cartridges and vials for the control of hyperglycaemia in adults with type 1 and 2 diabetes. In addition to developing prefilled cartridges, the companies intend to initiate clinical studies to demonstrate the advantages of NovoLog insulin and Paradigm pump therapy over other insulin therapies. The use of insulin pumps has been growing faster than the other major routes of administration - syringe and pen injection - on the back of data that suggest pumps can enhance glycaemic control and improved quality of life for insulin-requiring diabetic patients. People who use insulin pumps are said to enjoy increased di Continue reading >>
What Is Insulin Aspart (novolog, Novolog Flexpen, Novolog Penfill)?
A A A Medications and Drugs Brand Names: NovoLog, NovoLog FlexPen, NovoLog PenFill Generic Name: insulin aspart (Pronunciation: IN su lin AS part) What is the most important information I should know about insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? What should I discuss with my healthcare provider before using insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? What should I avoid while using insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Insulin is a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. Insulin aspart is a fast-acting form of insulin. Insulin aspart is used to treat type 1 (insulin-dependent) diabetes in adults and children who are at least 2 years old. Insulin aspart is usually given together with another long-acting insulin. Insulin aspart may also be used for other purposes not listed in this medication guide. What are the possible side effects of insulin aspart (NovoLog, NovoLog FlexPen, NovoLog PenFill)? Get emergency medical help if you have any of these signs of insulin allergy: itching skin rash over the entire body, wheezing, trouble breathing, fast heart rate, sweating, or feeling like you might pass out. Call your doctor if you have a serious side effect such as: swelling in your hands or feet; or low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling). Hypoglycemia, or low blood sugar, is the most common side effect of insulin aspart. Symptoms of low blood sugar may include headache, nausea, hunger, confusion, drowsiness, weakness, dizziness, blurred vision, fast heartbeat, sweating, tremor, trouble concentrating, confusion, or seizure (convulsions). Watch for signs of low blood sugar. Continue reading >>
Humalog Vs. Novolog: What’s The Difference?
The two leaders in the fast acting insulin market, Humalog and Novolog, are the most common types of fast acting insulin used by those with diabetes today. Fast Acting, mealtime insulin is a type of insulin that is injected before or right after eating. When you eat your blood glucose begins to rise. Fast acting insulin, Humalog and Novolog work to help manage these rises or spikes to keep your blood glucose levels more within range and balanced. When you use a fast acting insulin like Humalog or Novolog, you typically will continue to take a long acting insulin to help manage your levels between your meals and throughout the night. The question is though, is there really a difference between the two? Endocrinologists and other medical professionals don’t seem to really think there is, stating the two are virtually interchangeable. But that’s not really the full story. Humalog (Insulin Lispro) Insulin Lispro (Humalog) has been on the market since 1996, when it was first introduced by Eli Lily. Humalog is the first insulin analogue that was used clinically. Insulin Lispro received its name due to its structure. The difference between it and regular insulin was the switch between the lysine B28 (an amino acid) and proline B29. The formula consists of a hexametric solution available in vials and pen form. After a subcutaneous injection, the formula converts into a monomeric formula which allows it to have a fast absorption in the body. The one noted negative factor of Humalog is its short term control of glucose levels. Additionally, if it is injected and mealtime happens to be delayed, a hypoglycemic episode may occur. For Humalog to be most effective it is to be injected 15 minutes prior to the start of a meal. I recommend reading the following articles: Humalog is a Continue reading >>
Selected Important Safety Information
NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients. Never Share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® Cartridge, or PenFill® Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. NovoLog® (insulin aspart injection) 100 U/mL is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients. Never Share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® Cartridge, or PenFill® Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. Hypoglycemia is the most common adverse effect of insulin therapy. The timing of hypoglycemia may reflect the time-action profile of the insulin formulation. Glucose monitoring is re Continue reading >>
Novolog® (insulin Aspart Injection) 100 U/ml Indications And Usage
NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients. Never Share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® Cartridge, or PenFill® Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. NovoLog® (insulin aspart injection) 100 U/mL is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients. Never Share a NovoLog® FlexPen, NovoLog® FlexTouch®, PenFill® Cartridge, or PenFill® Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. Hypoglycemia is the most common adverse effect of insulin therapy. The timing of hypoglycemia may reflect the time-action profile of the insulin formulation. Glucose monitoring is re Continue reading >>
Takingnovolog
This website is intended for use by United States residents only. The content is for informational purposes only and is not intended to replace a discussion with a health care provider. Cornerstones4Care, FlexPen, NovoFine, NovoLog, NovoPen, NovoPen Echo, NovoTwist, PenFill, and PenMate are registered trademarks and NovoLogReach is a trademark of Novo Nordisk A/S. Novo Nordisk is a registered trademark of Novo Nordisk A/S. All other trademarks are the property of their respective owners. 2015 Novo Nordisk All rights reserved. 0915-00028584-1 December 2015 Details of Offer Including Restrictions on Eligibility and Other Limitations Restrictions & Limitations: You are not eligible if prescriptions are paid by any state or federally funded programs, including, but not limited to, Medicare, Medicaid, Medigap, VA, DOD, or TRICARE, or where prohibited by law. Offer not valid for Levemir FlexPen, NovoLog Mix 70/30 FlexPen, or NovoLog reimbursed in full by any third party payer. Offer limited to 1 card per patient. Offer void where taxed, restricted, or prohibited. Offer only good in the U.S.A. Eligibility is restricted to individuals; no clubs, groups, or organizations. This savings card is not transferable. When you use the Novo Nordisk Instant Savings Card, you are certifying that you understand the program rules, terms, and conditions and that you will comply with them. Offer Details: Pay no more than $25 (up to $100 discount) when you start on a Novo Nordisk product and for each refill for up to 2 years, and no more than $20 (up to $100 discount) for the next prescribed product and each refill for up to 2 years. Offer available for a 30-day supply of Levemir FlexPen (insulin detemir [rDNA origin] injection), NovoLog Mix 70/30 FlexPen (70% insulin aspart protamine suspensi Continue reading >>
Important Safety Information
Indications and Usage What is NovoLog® (insulin aspart injection) 100 U/mL? NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus. Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®, PenFill® cartridge or PenFill® cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. Who should not take NovoLog®? Do not take NovoLog® if: your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients. Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are: pregnant, plan to become pregnant, or are breastfeeding. taking new prescription or over-the-counter medicines, including supplements. Talk to your health care provider about how to manage low blood sugar. How should I take NovoLog®? Read the Instructions for Use and take exactly as directed. NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it. Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to. Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them. Do not reuse or share your needles with other people. You may give other people a serious infection, or get a serious infection from them. What should I avoid while taking NovoLog®? Do not drive or operate heavy machinery, until you know how NovoLog® affects you. Do not drink alcohol or use medicines that contain alcohol. What are the possible side effects of NovoLog®? Serious side effects can lead to death, including: Low blood sugar. Continue reading >>
What Is Novolog?
Commonly Used Brand Name(s)NovoLOG, NovoLOG FlexPen, NovoLOG PenFill Therapeutic ClassificationsAntidiabetic Pharmacologic ClassificationsInsulin, Ultra Rapid Acting QUICK LINKS Insulin aspart is a fast-acting type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus, your body cannot make enough or does not use insulin properly. So, you must take additional insulin to regulate your blood sugar and keep your body healthy. This is very important as too much sugar in your blood can be harmful to your health. Since insulin aspart acts faster than regular human insulin, you normally should use insulin aspart with a longer-acting insulin. This medicine is available only with your doctor's prescription. Find big savings at pharmacies near you with GoodRx discount coupons Lowest GoodRx Price $426.00 View All Prices A nurse or other trained health professional may give you this medicine. You may also be taught how to give your medicine at home. This medicine is given as a shot under your skin or into a vein. Always double-check both the concentration (strength) of your insulin and your dose. Concentration and dose are not the same. The dose is how many units of insulin you will use. The concentration tells how many units of insulin are in each milliliter (mL), such as 100 units/mL (U-100), but this does not mean you will use 100 units at a time. Each package of insulin aspart contains a patient information sheet. Read this sheet carefully before beginning treatment and each time you refill for any new information, and make sure you understand: How to prepare the medicine. Ho Continue reading >>
Novolog Penfill U-100 Insulin Aspart Subcutaneous : Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - Webmd
Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes . Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke . Insulin aspart is a man-made product that is similar to human insulin . It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar ( glucose ) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Read the Patient Information Leaflet provided by your pharmacist before you start using this medication and each time you get a refill. If you have any questions, ask your doctor, diabetes educator, or pharmacist. Learn all preparation and usage instructions from your health care professional and the product package. Before using, check this product visually for particles or discoloration. If either is present, do not use the insulin . Insulin aspart should be clear and colorless. Before injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin and to avoid developing problems under the skin ( lipodystrophy ). Insulin aspart may be injected in the stomach area, the thigh, or the back of the upper arm. Do not inject into skin that is red, swollen, or itchy. Do not inject cold insulin because this can be painful. The insulin container you are currently using can be kept at room temperature. Inject this medication under the skin as directed by your doctor. Some brands should be injecte Continue reading >>
These Highlights Do Not Include All The Information Needed To Use Novolog Safely And Effectively. See Full Prescribing Information For Novolog.novolog (insulin Aspart Injection), For Subcutaneous Or Intravenous Useinitial U.s. Approval: 2000
In patients with hypersensitivity to NOVOLOG or one of its excipients, [see Warnings and Precautions ( 5.5 )] 5.1 Never Share NOVOLOG FlexPen, NOVOLOG FlexTouch, PenFill Cartridge or PenFill Cartridge Device Between Patients NOVOLOG FlexPen, NOVOLOG FlexTouch, PenFill cartridge, and PenFill cartridge devices should never be shared between patients, even if the needle is changed. Patients using NOVOLOG vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. 5.2 Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia [See Warnings and Precautions (5.3)] or hyperglycemia. These changes should be made cautiously and only under close medical supervision, and the frequency of blood glucose monitoring should be increased. For patients with type 2 diabetes, dosage adjustments of concomitant anti-diabetic products may be needed. Hypoglycemia is the most common adverse effect of all insulin therapies, including NOVOLOG. Severe hypoglycemia can cause seizures, may lead to unconsciousness may be life threatening or cause death. Hypoglycemia can impair concentration ability and reaction time; this may place an individual and others at risk in situations where these abilities are important (e.g. driving or operating other machinery). Hypoglycemia can happen suddenly and symptoms may differ in each individual and change over time in the same individual. Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta Continue reading >>
Novocare | Savings Card For Novolog (insulin Aspart Injection) 100 Units/ml
Some error has occurred. Please try again. User already exists. We're sorry, your account is currently unavailable. We're currently working to fix the issue. Please check back soon. {{registerModel.webserviceError}} Do not share your NovoLog FlexPen, NovoLog FlexTouch, PenFill cartridge or PenFill cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients. Read the Instructions for Use and take exactly as directed. NovoLog is fast-acting. Eat a meal within 5 to 10 minutes after taking it. Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to. Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them. Do not reuse or share your needles with other people. You may give other people a serious infection, or get a serious infection from them. What is NovoLog(insulin aspart injection) 100 U/mL? NovoLogis a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus. Do not share your NovoLog FlexPen, NovoLog FlexTouch, PenFill cartridge or PenFill cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients. Before taking NovoLog, tell your health care provider about all your medical conditions including, if you are: pregnant, plan to become pregnant, or are breastfeeding. taking Continue reading >>
What Are The Possible Side Effects Of Insulin Aspart (novolog, Novolog Flexpen, Novolog Penfill)?
NOVOLOG (insulin aspart) Injection DESCRIPTION NOVOLOG (insulin aspart injection) is a rapid-acting human insulin analog used to lower blood glucose. NOVOLOG is homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C256H381N65O79S6 and a molecular weight of 5825.8. Figure 1: Structural formula of insulin aspart NOVOLOG is a sterile, aqueous, clear, and colorless solution, that contains insulin aspart 100 Units/mL, glycerin 16 mg/mL, phenol 1.50 mg/mL, metacresol 1.72 mg/mL, zinc 19.6 mcg/mL, disodium hydrogen phosphate dihydrate 1.25 mg/mL, sodium chloride 0.58 mg/mL and water for injection. NOVOLOG has a pH of 7.2-7.6. Hydrochloric acid 10% and/or sodium hydroxide 10% may be added to adjust pH. font size A A A 1 2 3 4 5 Next What is Type 2 Diabetes? The most common form of diabetes is type 2 diabetes, formerly called non-insulin dependent diabetes mellitus or "adult onset" diabetes, so-called because it typically develops in adults over age 35, though it can develop at any age. Type 2 diabetes is diagnosed more often in people who are overweight or obese, and who are not physically active. Type 2 diabetes is an illness in which the body does not process ingested sugars (glucose) properly. In type 2, the body usually produces some insulin, but not enough to allow the glucose into the cells for the body to use as energy. In addition, there can be insulin resistance, where it becomes difficult for the body to use the insulin produced. Type 2 diabetes is seen both in men and in women, though men have a slightly higher incidence of developing the dise Continue reading >>
Novolog Penfill Solution For Injection Drug Information, Side Effects, Faqs
-an unusual or allergic reaction to insulin, metacresol, other medicines, foods, dyes, or preservatives This medicine is for injection under the skin. Use exactly as directed. It is important to follow the directions given to you by your health care professional or doctor. If you are using Novolog, you should start your meal within 5 to 10 minutes after injection. If you are using Fiasp, you should start your meal at the time of injection or within 20 minutes after injection. Have food ready before injection. Do not delay eating. You will be taught how to use this medicine and how to adjust doses for activities and illness. Do not use more insulin than prescribed. Do not use more or less often than prescribed. Always check the appearance of your insulin before using it. This medicine should be clear and colorless like water. Do not use if it is cloudy, thickened, colored, or has solid particles in it. If you use a pen, be sure to take off the outer needle cover before using the dose. It is important that you put your used needles and syringes in a special sharps container. Do not put them in a trash can. If you do not have a sharps container, call your pharmacist or healthcare provider to get one. Talk to your pediatrician regarding the use of this medicine in children. While Novolog may be prescribed for children as young as 2 years of age for selected conditions, precautions do apply. Fiasp is not approved for use in children. It is important not to miss a dose. Your health care professional or doctor should discuss a plan for missed doses with you. If you do miss a dose, follow their plan. Do not take double doses. Visit your health care professional or doctor for regular checks on your progress. A test called the HbA1C (A1C) will be monitored. This is a simple bloo Continue reading >>
